Is it important to you to have accurate information about drugs?
Donate $30 to help keep Erowid going strong!

MDMA References Database

References Search
All References in Collection MDMA


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Merck E Merck MDMA Patent German Patent Office 1914
Roberts AS, Alexander F Report on Clinical Evaluation of SKF #5 (Amphedoxamine) [MDA] [Memo, 1957 Aug 21] 1957
Kristensen KK Kliniske erfaringer med psilocybin Nord. psykiat. T. 1963
Jackson B, Reed A Jr Another Abusable Amphetamine JAMA 1970
Gaston TR, Rasmussen GT Identification of 3,4 methylenedioxymethamphetamine Bureau of Narcotics ... 1972
Sreenivasan VR Problems in Identification of Methylenediony and Methoxy Amphetamines Journal of Criminal ... 1972
Hardman HF, Haavik CO, Se... Relationship of the structure of mescaline and seven analogs to toxici... Toxicol Appl Pharmac... 1973
Turek IS, Soskin RA, Kurl... Methylenedioxyamphetamine (MDA) Subjective Effects Journal of Psychedel... 1974
Nichols DE, Ilhan M, Long... Comparison of Cardiovascular, Hyperthermic, and Toxic Effects of Para-... Arch Int de Pharmaco... 1975
Lopatka JE, Brewerton CN,... The protective effects of methysergide, 6-hydroxydopamine and other ag... Res Commun Chem Path... 1976
Yensen R, Di Leo FB, Rhea... MDA-assisted psychotherapy with neurotic outpatients: a pilot study J Nerv Ment Dis 1976
Anderson GM 3d, Braun G, ... Absolute configuration and psychotomimetic activity NIDA Res Monogr 1978
Shulgin AT, Nichols DE Characterization of three new psychotomimetics. The Pharmacology of Ha... The Psychopharmacolo... 1978
Poklis A, Mackell MA, Dra... Fatal intoxication from 3,4-methylenedioxyamphetamine J Forensic Sci 1979
Lukaszewski T 3,4-methylenedioxyamphetamine overdose Clin Toxicol 1979
Strassman RJ, Galanter M The Abhidharma: a cross-cultural model for the psychiatric application... Int J Soc Psychiatry 1980
Braun U, Shulgin AT, Brau... Centrally active N-substituted analogs of 3,4- methylenedioxyphenyliso... J Pharm Sci 1980
O'Brien BA, Bonicamp JM, ... Differentiation of Amphetamine and Its Major Hallucinogenic Derivative... J Anal Toxicol 1982
Nichols DE, Lloyd DH, Hof... Effects of certain hallucinogenic amphetamine analogues on the release... J Med Chem 1982
Davis WM, Borne RF Pharmacologic investigation of compounds related to 3,4-methylenedioxy... Subst Alcohol Action... 1984
Ricaurte G, Bryan G, Stra... Hallucinogenic amphetamine selectively destroys brain serotonin nerve ... Science 1985
Gehlert DR, Schmidt CJ, W... Evidence for specific methylenedioxymethamphetamine (ecstasy) binding ... Eur J Pharmacol 1985
Mack RB A bit on the Wilde side: MDMA abuse N C Med J 1985
Riedlinger JE The scheduling of MDMA: a pharmacist's perspective J Psychoactive Drugs 1985
Ziporyn T A growing industry and menace: makeshift laboratory's designer drugs JAMA 1986
Seymour RB, Wesson DR, Sm... MDMA (3,4-methylenedioxymethamphetamine): proceedings of the conferenc... J Psychoactive Drugs 1986
Seymour RB, Wesson DR, Sm... Editor's Introduction J Psychoactive Drugs 1986
Beardsley PM, Balster RL,... Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus ... Drug Alcohol Depend 1986
Beck J MDMA: The popularization and resultant implications of a recently cont... Contemporary Drug Pr... 1986
Beck J, Morgan PA Designer drug confusion: a focus on MDMA J Drug Educ 1986
Brady JF, Di Stefano EW, ... Spectral and inhibitory interactions of (+/-)-3,4-methylenedioxyamphet... Life Sci 1986
Buffum J, Moser C MDMA and human sexual function J Psychoactive Drugs 1986
Climko RP, Roehrich H, Sw... Ecstacy: a review of MDMA and MDA Int J Psychiatry Med 1986
Commins DL, Vosmer G, Vir... Biochemical and histological evidence that methylenedioxymethylampheta... J Pharmacol Exp Ther 1986
Downing J The psychological and physiological effects of MDMA on normal voluntee... J Psychoactive Drugs 1986
Evans SM, Johanson CE Discriminative stimulus properties of (+/-)-3,4-methylenedioxymethamph... Drug Alcohol Depend 1986
Greer G, Tolbert R Subjective reports of the effects of MDMA in a clinical setting J Psychoactive Drugs 1986
Grinspoon L, Bakalar JB Can drugs be used to enhance the psychotherapeutic process? Am J Psychother 1986
Hayner GN, McKinney H MDMA. The dark side of ecstasy J Psychoactive Drugs 1986
Holsten DW, Schieser DW Controls over the manufacture of MDMA J Psychoactive Drugs 1986
Johnson MP, Hoffman AJ, N... Effects of the enantiomers of MDA, MDMA and related analogues on [3H]s... Eur J Pharmacol 1986
Kamien JB, Johanson CE, S... The effects of (+/-)-methylenedioxymethamphetamine and (+/-)-methylene... Drug Alcohol Depend 1986
Leverant R MDMA reconsidered J Psychoactive Drugs 1986
Lyon RA, Glennon RA, Tite... 3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions... Psychopharmacology (... 1986
Newmeyer JA Some considerations on the prevalence of MDMA use J Psychoactive Drugs 1986
Nichols DE Differences between the mechanism of action of MDMA, MBDB, and the cla... J Psychoactive Drugs 1986
Noggle FT Jr, DeRuiter J,... Spectrophotometric and liquid chromatographic identification of 3,4-me... J Assoc Off Anal Che... 1986
Renfroe CL MDMA on the street: Analysis Anonymous J Psychoactive Drugs 1986
Schechter MD Discriminative profile of MDMA Pharmacol Biochem Be... 1986
Schmidt CJ, Wu L, Lovenbe... Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine an... Eur J Pharmacol 1986
Shulgin AT The background and chemistry of MDMA J Psychoactive Drugs 1986
Siegel RK MDMA-Nonmedical use and intoxication J Psychoactive Drugs 1986
Stone DM, Stahl DC, Hanso... The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methyl... Eur J Pharmacol 1986
Wolfson PE Meetings at the edge with Adam: A man for all seasons? J Psychoactive Drugs 1986
Davis WM, Catravas JD, Wa... Effects of an i.v. lethal dose of 3,4-methylenedioxyamphetamine (MDA) ... Gen Pharmacol 1986
Callaway E The Biology of Human Information Processing J Psychoactive Drugs 1986
Battaglia G, Yeh SY, O'He... 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine de... J Pharmacol Exp Ther 1987
Boja JW, Schechter MD Behavioral effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE; 'EVE... Pharmacol Biochem Be... 1987
Brown C, Osterloh J Multiple severe complications from recreational ingestion of MDMA ('Ec... JAMA 1987
Davis WM, Hatoum HT, Wate... Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevan... Alcohol Drug Res 1987
Dowling GP, McDonough ET ... 'Eve' and 'Ecstasy'. A report of five deaths associated with the use o... JAMA 1987
Frith CH, Chang LW, Latti... Toxicity of methylenedioxymethamphetamine (MDMA) in the dog and the ra... Fundam Appl Toxicol 1987
Gibb JW, Stone DM, Stahl ... The effects of amphetamine-like designer drugs on monoaminergic system... NIDA Res Monogr 1987
Glennon RA, Little PJ, Ro... The effect of MDMA ('Ecstasy') and its optical isomers on schedule-con... Pharmacol Biochem Be... 1987
Kulmala HK, Boja JW, Sche... Behavioral suppression following 3,4-methylenenedioxymethamphetamine Life Sci 1987
Lamb RJ, Griffiths RR Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the ... Psychopharmacology (... 1987
Mokler DJ, Robinson SE, R... (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reduc... Eur J Pharmacol 1987
Noggle FT Jr, DeRuiter J,... Synthesis, identification, and acute toxicity of some N-alkyl derivati... J Assoc Off Anal Che... 1987
Peroutka SJ Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine... N Engl J Med 1987
Peroutka SJ, Pascoe N, Fa... Monoamine metabolites in the cerebralspinal fluid of recreational user... Research Comm in Sub... 1987
Ricaurte GA, Finnegan KF,... 3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, pr... Eur J Pharmacol 1987
Rosecrans JA, Glennon RA The effect of MDA and MDMA ('Ecstasy') isomers in combination with pir... Pharmacol Biochem Be... 1987
Schechter MD MDMA as a discriminative stimulus: isomeric comparisons Pharmacol Biochem Be... 1987
Schmidt CJ Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphet... J Pharmacol Exp Ther 1987
Smilkstein MJ, Smolinske ... A case of MAO inhibitor/MDMA interaction: agony after ecstasy J Toxicol Clin Toxic... 1987
Steele TD, Nichols DE, Yi... Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and... Biochem Pharmacol 1987
Stone DM, Hanson GR, Gibb... Differences in the central serotonergic effects of methylenedioxymetha... Neuropharmacology 1987
Stone DM, Johnson M, Hans... A comparison of the neurotoxic potential of methylenedioxyamphetamine ... Eur J Pharmacol 1987
Stone DM, Merchant KM, Ha... Immediate and long-term effects of 3,4-methylenedioxymethamphetamine o... Neuropharmacology 1987
Thompson DM, Winsauer PJ,... Effects of phencyclidine, ketamine and MDMA on complex operant behavio... Pharmacol Biochem Be... 1987
Wang SS, Ricaurte GA, Per... [3H]3,4-methylenedioxymethamphetamine (MDMA) interactions with brain m... Eur J Pharmacol 1987
Finnegan KT, Ricaurte GA,... Orally administered MDMA causes a long-term depletion of serotonin in ... Brain Res 1988
Barnes DM Ecstasy returns to Schedule I Science 1988
Battaglia G, Brooks BP, K... Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at v... Eur J Pharmacol 1988
Battaglia G, Yeh SY, de S... MDMA-induced neurotoxicity: parameters of degeneration and recovery of... Pharmacol Biochem Be... 1988
Bost RO 3,4-Methylenedioxymethamphetamine (MDMA) and other amphetamine derivat... J Forensic Sci 1988
Buchanan JF, Brown CR 'Designer drugs'. A problem in clinical toxicology Med Toxicol Adverse ... 1988
Callahan PM, Appel JB Differences in the stimulus properties of 3,4-methylenedioxyamphetamin... J Pharmacol Exp Ther 1988
Glennon RA, Yousif M, Pat... Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MD... Pharmacol Biochem Be... 1988
Gold LH, Koob GF Methysergide potentiates the hyperactivity produced by MDMA in rats Pharmacol Biochem Be... 1988
Hubner CB, Bird M, Rassni... The threshold lowering effects of MDMA (ecstasy) on brain-stimulation ... Psychopharmacology (... 1988
Johnson M, Hanson GR, Gib... Effects of dopaminergic and serotonergic receptor blockade on neuroche... Neuropharmacology 1988
Johnson M, Letter AA, Mer... Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamp... J Pharmacol Exp Ther 1988
Lim HK, Foltz RL In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine... Chem Res Toxicol 1988
Logan BJ, Laverty R, Sand... Differences between rats and mice in MDMA (methylenedioxymethylampheta... Eur J Pharmacol 1988
Mamounas LA, Molliver ME Evidence for dual serotonergic projections to neocortex: axons from th... Exp Neurol 1988
Nash JF Jr, Meltzer HY, G... Elevation of serum prolactin and corticosterone concentrations in the ... J Pharmacol Exp Ther 1988
Nencini P, Woolverton WL,... Enhancement of morphine-induced analgesia after repeated injections of... Brain Res 1988
Oberlender R, Nichols DE Drug discrimination studies with MDMA and amphetamine Psychopharmacology (... 1988
O'Hearn E, Battaglia G, D... Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDM... J Neurosci 1988

Page 1 of 16   /   1573 Entries Returned
Pages:     
 1 
2 3 4 5 6 7 8 9 10 11 12 13 14 15 next
  16                



Erowid.org Plants & Drugs Mind & Spirit Freedom & Law Arts & Sciences Search About Erowid and Feedback Library & Bookstore Copyrights Memberships noref